Research with Dual Use Potential. Presentation Nancy Connell, Yousra Sobeih and Alastair Hay

Size: px
Start display at page:

Download "Research with Dual Use Potential. Presentation Nancy Connell, Yousra Sobeih and Alastair Hay"

Transcription

1 Research with Dual Use Potential Presentation Nancy Connell, Yousra Sobeih and Alastair Hay

2 Research with Dual Use Potential Goal: To have a better understanding of the concept of dual use Objective: To be able to identify research with dual use potential

3 Dual Use Research: Where the results have the potential to benefit as well as harm *Information Note: Conference on Dual Use Research of Concern (Life Sciences) Switzerland, Feb Potential risks posed by accidents or deliberate misuse of life sciences research **Responsible Life Sciences Research for Global Health Security: A Guidance Report, WHO 2010

4 Group Work Read Listeria factsheet & try to answer: (10 min) Your research team is studying Listeria monocytogenes for wide research purposes. To study listeria host range, most likely you will use: A. Human Clinical Cases B. Experimental Animals

5 Listeria

6

7 Group Work (5 min) Within your group discuss: What do you think of this piece of research? Will it be helpful in studying the disease?

8

9

10 Group Work (2 min) Within your group discuss: Was this responsible media reporting?

11 *Types of Risks Knowledge or techniques could help to create novel pathogens with unique properties or create entirely new classes of threat agents Research could have unintended consequences Research results can be published in easily accessible journals and on the internet and could be misused. * Source: PowerPoint Presentation, Research with Dual-Use Potential Session by John Clements, Educational Institute on Responsible Research with infectious Diseases, Aqaba, Jordon

12 *Examples of Risks ** Reconstructing 1918 Influenza Virus (A H1N1 pandemic virus, known as the Spanish Flu virus) Concerns: Escape from laboratories Deliberate misuse to cause harm Research-related laboratory accidents Soldiers from Fort Riley, Kansas, ill with Spanish influenza at a hospital ward at Camp Funston. en.wikipedia.org/ * Source: Responsible life sciences research for global health security: A guidance document, 2010, World Health Organization (WHO) ** Source: Tumpey TM et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science, 2005, 310:77 80

13 *Examples of Risks **Increasing the virulence of mousepox (As part of an experiment to create a contraceptive vaccine for mice as a means of pest control) Concerns: Genetic manipulation results Similar experiments on orthopox viruses (such as smallpox) This work provided information that could be used to make the smallpox vaccine less or ineffective *Source: Responsible life sciences research for global health security: A guidance document, 2010, World Health Organization (WHO) ** Jackson RJ et al. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. Journal of Virology, 2001, 75: *Source: Responsible life sciences research for global health security: A guidance document, 2010, World Health Organization (WHO)

14 Research benefits vs. the risks of its misuse

15 Group Work (10 min) Are there some experiments that you would not do because the results could be misused? What are they? Create a definition of dual use and present to all

16 Group Work (10 min) What should stop a scientist from doing research where the risk is greater than the benefits? Is it ethics, regulations, or

17 * Researcher Responsibility All who participate in biomedical research have a moral & ethical obligation to consider the implications of possible malicious use of their findings (Frida Kuhlau, Kathinka Evers, Stefan Eriksson and Anna T. Hoglund: Ethical Competence in Dual Use Life Science Research. Applied Biosafty, Vol. 17 no.3, P.g

18 Research with Dual Use Potential Goal: To have a better understanding of the concept of dual use Objective: To be able to identify research with dual use potential

19 Thank you

Proliferation Threats from Biotechnology: What is Dual-Use Research?

Proliferation Threats from Biotechnology: What is Dual-Use Research? Proliferation Threats from Biotechnology: What is Dual-Use Research? In Class Discussion Break into groups of 3, come up with definition dual use and present to class Biological Dual-Use Research Biotechnology

More information

When should scientists keep their mouths shut?

When should scientists keep their mouths shut? When should scientists keep their mouths shut? Tina Liu Censorship in the past: recombinant DNA research Ann Fiegen Censorship today: A dangerous flu virus created? How and why. Kevin Bonham Weighing the

More information

Cristina Cassetti, Ph.D.

Cristina Cassetti, Ph.D. NIAID Extramural Research Update: Recombinant Influenza Viruses and Biosafety Cristina Cassetti, Ph.D. Influenza Program Officer Division of Microbiology and Infectious Diseases NIAID Influenza virus DMID

More information

The H5N1 Influenza Controversy: Implications for Science Governance. Larry Kerr, PhD Senior Advisor to the Director for Global Biological Threats

The H5N1 Influenza Controversy: Implications for Science Governance. Larry Kerr, PhD Senior Advisor to the Director for Global Biological Threats The H5N1 Influenza Controversy: Implications for Science Governance Larry Kerr, PhD Senior Advisor to the Director for Global Biological Threats Palais des Nations Room Geneva, Switzerland 17 July 2012

More information

1. Ethics and Dual-Use Research

1. Ethics and Dual-Use Research Michael J. Selgelid [W]ho is most capable of treating friends well and enemies badly in matters of disease and health? A doctor. Isn t the person most able to land a blow, whether in boxing or any other

More information

Potential Threats from Biotechnology and Life Sciences: What is Dual-Use Research?

Potential Threats from Biotechnology and Life Sciences: What is Dual-Use Research? Potential Threats from Biotechnology and Life Sciences: What is Dual-Use Research? Adapted from presentation by Nonproliferation Education Program James Martin Center for Nonproliferation Studies Monterey

More information

Biosafety and Bioethics

Biosafety and Bioethics Biosafety and Bioethics Special Challenges of Gain-of Function Experiments and Potential Pandemic Pathogens Marc Lipsitch, D.Phil. Eagleson Lecture, ABSA October 22, 2013 Kansas City Funded by the National

More information

Pandemic Influenza influenza epidemic: realization of a worst-case scenario

Pandemic Influenza influenza epidemic: realization of a worst-case scenario Pandemic Influenza October 9, 2006 1918 influenza epidemic: realization of a worst-case scenario First case: Albert Mitchell, Camp Funston, KS, March 11, 1918 Up to 20% of all humans infected 20-50 million

More information

A conversation with Michael Osterholm on July 30, 2013 about pandemics

A conversation with Michael Osterholm on July 30, 2013 about pandemics A conversation with Michael Osterholm on July 30, 2013 about pandemics Participants Michael Osterholm Director, Center for Infectious Disease Research and Policy (CIDRAP), University of Minnesota Alexander

More information

Humanitarian Logistics & Pandemic Influenza

Humanitarian Logistics & Pandemic Influenza Humanitarian Logistics & Pandemic Influenza Alastair Cook Budapest 22 nd October, 2009 Pandemic Influenza Influenza pandemics are naturally occurring events Influenza pandemics occur 2 3 times each century

More information

IN VIVO STUDIES ON VIRAL VIRULENCE

IN VIVO STUDIES ON VIRAL VIRULENCE IN VIVO STUDIES ON VIRAL VIRULENCE M.Phil student: Emily TSUI Supervisor: Professor Paul K.S Chan Department of Microbiology, CUHK Date: 15th Dec, 2014 Viral Virulence Capacity of a virus to cause disease

More information

Global Catastrophic Biological Risks

Global Catastrophic Biological Risks Global Catastrophic Biological Risks Working Definition of Global Catastrophic Biological Risks (GCBRs) Events in which biological agents whether naturally emerging or reemerging, deliberately created

More information

Risk and Benefit Analysis (RBA) of Gain of Function Research Gaps and Future Considerations

Risk and Benefit Analysis (RBA) of Gain of Function Research Gaps and Future Considerations Science. Security. Strategy. Risk and Benefit Analysis (RBA) of Gain of Function Research Gaps and Future Considerations Gryphon Scientific Rocco Casagrande, PhD, Principal Investigator NAS Meeting February

More information

Lecture 19 Evolution and human health

Lecture 19 Evolution and human health Lecture 19 Evolution and human health The evolution of flu viruses The evolution of flu viruses Google Flu Trends data US data Check out: http://www.google.org/flutrends/ The evolution of flu viruses the

More information

Considerations in Risk Assessment for Dangerous Pathogens

Considerations in Risk Assessment for Dangerous Pathogens Science. Security. Strategy. Considerations in Risk Assessment for Dangerous Pathogens Rocco Casagrande, Ph.D. Gryphon Scientific Agenda Today, I will describe some of the lessons learned after conducting

More information

LESSON 4.5 WORKBOOK. How do viruses adapt Antigenic shift and drift and the flu pandemic

LESSON 4.5 WORKBOOK. How do viruses adapt Antigenic shift and drift and the flu pandemic DEFINITIONS OF TERMS Gene a particular sequence of DNA or RNA that contains information for the synthesis of a protien or RNA molecule. For a complete list of defined terms, see the Glossary. LESSON 4.5

More information

2000 and Beyond: Confronting the Microbe Menace 1999 Holiday Lectures on Science Chapter List

2000 and Beyond: Confronting the Microbe Menace 1999 Holiday Lectures on Science Chapter List 2000 and Beyond: Confronting the Microbe Menace 1999 Holiday Lectures on Science Chapter List Lecture One Microbe Hunters: Tracking Infectious Agents Donald E. Ganem, M.D. 1. Start of Lecture One 2. Introduction

More information

Meta Analysis: Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?

Meta Analysis: Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment? Meta Analysis: Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment? Luke TC, Kilbane EM, Jackson JE, Hoffman SL. Annals of Internal Medicine. 2006 Oct 17;145(8):599-609. Annual Death

More information

INFLUENZA A VIRUS. Structure of the influenza A virus particle.

INFLUENZA A VIRUS. Structure of the influenza A virus particle. INFLUENZA INFLUENZA A VIRUS Structure of the influenza A virus particle. TYPE A VIRUS HAS TWO TYPES OF SPIKES, THE HEMAGGLUTININ (H) AND THE NEURAMINIDASE (N), PROTRUDING FROM THE VIRAL ENVELOPE THE HEMAGGLUTININ

More information

Influenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong

Influenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong Influenza Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong Classification & Nomenclature Influenza virus A, B & C Influenza A : Haemagglutinin (H 1-16), neuraminidase (N1-9)

More information

Implications of Life Sciences R&D for Global Health Security

Implications of Life Sciences R&D for Global Health Security Implications of Life Sciences R&D for Global Health Security Dr Ottorino Cosivi Project Leader, Preparedness for Deliberate Epidemics Department of Epidemic and Pandemic Alert and Response WHO s Public

More information

Conversation with Tom Inglesby on October 2, 2013

Conversation with Tom Inglesby on October 2, 2013 Participants Conversation with Tom Inglesby on October 2, 2013 Tom Inglesby, M.D., Chief Executive Officer and Director, University of Pittsburgh Medical Center (UPMC) Center for Health Security Alexander

More information

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS APRIL 2017 Infectious viruses are a global health threat Since the approval of the first antiviral drug

More information

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS MAY 2017 1 Infectious viral pathogens are a significant global health threat to mankind 2 Since the approval

More information

Memory NK cells during mousepox infection. Min Fang, Ph.D, Professor Institute of Microbiology, Chinese Academy of Science

Memory NK cells during mousepox infection. Min Fang, Ph.D, Professor Institute of Microbiology, Chinese Academy of Science Memory NK cells during mousepox infection Min Fang, Ph.D, Professor Institute of Microbiology, Chinese Academy of Science Infectious Diseases are a Major Cause of Death Worldwide May 14 th 1796 Prevalence

More information

Lecture 10 Immune System

Lecture 10 Immune System Lecture 10 Immune System Lecture 10 1. Introduction 2. Nonspecific External Defenses 3. Innate Immune Response 4. Acquired Immune Response 5. Antibiotics and Vaccines 1 The not-so-common cold A cold is

More information

erils of Manufactured Diseases ented by Christopher Bossert

erils of Manufactured Diseases ented by Christopher Bossert erils of Manufactured Diseases ented by Christopher Bossert Introduction: Superbugs In 1928, penicillin was discovered the first true antibiotic. From then until now, we have steadily developed stronger

More information

Guidelines for clinical management of severe influenza infection. Aeron Hurt

Guidelines for clinical management of severe influenza infection. Aeron Hurt Guidelines for clinical management of severe influenza infection Aeron Hurt Current WHO guidelines WHO guidance documents for the clinical management of influenza virus infection were published in 2007

More information

The Immune System and Pathology

The Immune System and Pathology The Immune System and Pathology The Immune System in Action When a mosquito bites When you breathe When you have allergies When you get a blood transfusion When you die...also called the Lymphatic System

More information

Scientific Minimalism and the Division of Moral Labor in Regulating Dual-Use Research Steven Dykstra

Scientific Minimalism and the Division of Moral Labor in Regulating Dual-Use Research Steven Dykstra 33 Scientific Minimalism and the Division of Moral Labor in Regulating Dual-Use Research Steven Dykstra Abstract: In this paper I examine the merits of a division of moral labor regulatory system for dual-use

More information

Biosafety Basics. Patrick Stockton, Director, Office of Biosafety Biosafety Community Liaison Committee June 26, 2017

Biosafety Basics. Patrick Stockton, Director, Office of Biosafety Biosafety Community Liaison Committee June 26, 2017 Biosafety Basics Patrick Stockton, Director, Office of Biosafety Biosafety Community Liaison Committee June 26, 2017 What is Biosafety? The discipline that addresses how to provide guidance and assistance

More information

Bioterrorism and the Pandemic Potential

Bioterrorism and the Pandemic Potential Page 1 of 5 Bioterrorism and the Pandemic Potential March 7, 2013 1001 GMT Print 38 35 125 29 Text Size Stratfor By Rebecca Keller Periodic media reports of bird flu, a new SARS-like virus and a case of

More information

Cloudbreak. March Cidara Therapeutics

Cloudbreak. March Cidara Therapeutics Cloudbreak March 2019 Cidara Therapeutics 2019 0 Forward-Looking Statements These slides and the accompanying oral presentation contain forward-looking statements within the meaning of the Private Securities

More information

Frequently Asked Questions on Avian Influenza

Frequently Asked Questions on Avian Influenza Frequently Asked Questions on Avian Influenza What is bird flu (avian influenza) and how does it differ from seasonal flu and pandemic influenza? Avian influenza or bird flu is a disease of birds caused

More information

Overview: Chapter 19 Viruses: A Borrowed Life

Overview: Chapter 19 Viruses: A Borrowed Life Overview: Chapter 19 Viruses: A Borrowed Life Viruses called bacteriophages can infect and set in motion a genetic takeover of bacteria, such as Escherichia coli Viruses lead a kind of borrowed life between

More information

1/29/2013. Viruses and Bacteria. Infectious Disease. Pathogens cause disease by: Chapters 16 and 17

1/29/2013. Viruses and Bacteria. Infectious Disease. Pathogens cause disease by: Chapters 16 and 17 Viruses and Bacteria Chapters 16 and 17 Infectious Disease Caused by the invasion of a host by agents whose activities harm the host s tissues Can be transmitted to others Pathogen microorganisms that

More information

Nanoparticulate Vaccine Design: The VesiVax System

Nanoparticulate Vaccine Design: The VesiVax System Nanoparticulate Vaccine Design: The VesiVax System Gary Fujii, Ph.D. President and CEO Molecular Express, Inc. May 16, 2006 Orlando, Florida Influenza Each year up to 20% of the world's population contracts

More information

Dual Use Research of Concern: Balancing the Risks and Rewards of Current and Future Life Sciences Research. Deborah Howard

Dual Use Research of Concern: Balancing the Risks and Rewards of Current and Future Life Sciences Research. Deborah Howard Dual Use Research of Concern: Balancing the Risks and Rewards of Current and Future Life Sciences Research by Deborah Howard A Master s Paper submitted to the faculty of the University of North Carolina

More information

Epidemiology Treatment and control Sniffles and Sneezes Mortality Spanish flu Asian flu Hong Kong flu The Swine flu scare

Epidemiology Treatment and control Sniffles and Sneezes Mortality Spanish flu Asian flu Hong Kong flu The Swine flu scare Epidemiology Treatment and control Sniffles and Sneezes Mortality Spanish flu Asian flu Hong Kong flu The Swine flu scare Epidemiology The Flu Virus Influenza is commonly called the flu. The most deadly

More information

Staff Immunisation Policy

Staff Immunisation Policy Policy No: IC05 Version: 8.0 Name of Policy: Staff Immunisation Policy Effective From: 18/08/2015 Date Ratified 15/07/2015 Ratified Infection Prevention & Control Committee Review Date 01/07/2017 Sponsor

More information

New Delhi International Ministerial Conference on Avian and Pandemic Influenza Dec 4-6th, 2007

New Delhi International Ministerial Conference on Avian and Pandemic Influenza Dec 4-6th, 2007 New Delhi International Ministerial Conference on Avian and Pandemic Influenza Dec 4-6th, 2007 Session IV Influenza Pandemic Preparedness Dr Paul R Gully Health Security and Environment, Geneva Avian Influenza

More information

ANALYZING AND MANAGING RISKS IN LIFE SCIENCES RESEARCH

ANALYZING AND MANAGING RISKS IN LIFE SCIENCES RESEARCH Practical Training Exercise ANALYZING AND MANAGING RISKS IN LIFE SCIENCES RESEARCH Based on the article by Siddique, N. et al. Sequence and phylogenetic analysis of highly pathogenic avian influenza H5N1

More information

Housing of Different Infected Mice in the Same Room: How to Prevent Roommate Conflicts? Jocelyn Beaucher, PhD, microbiologist Biosafety Officer

Housing of Different Infected Mice in the Same Room: How to Prevent Roommate Conflicts? Jocelyn Beaucher, PhD, microbiologist Biosafety Officer Housing of Different Infected Mice in the Same Room: How to Prevent Roommate Conflicts? Jocelyn Beaucher, PhD, microbiologist Biosafety Officer L Université de Sherbrooke Located in the Eastern Townships,

More information

Global Challenges of Pandemic and Avian Influenza. 19 December 2006 Keiji Fukuda Global influenza Programme

Global Challenges of Pandemic and Avian Influenza. 19 December 2006 Keiji Fukuda Global influenza Programme Global Challenges of Pandemic and Avian Influenza 19 December 2006 Keiji Fukuda Global influenza Programme Summary of Current H5N1 Situation 1997 First known outbreak infecting humans 18 people hospitalized

More information

Viruses: Select Agents and Emerging Pathogens. Patricia Bolívar MS., CLS, PHM

Viruses: Select Agents and Emerging Pathogens. Patricia Bolívar MS., CLS, PHM Viruses: Select Agents and Emerging Pathogens Patricia Bolívar MS., CLS, PHM Objectives Review Select Agent Viruses. Key features to recognize Smallpox virus Update on emerging Viruses of possible pandemic

More information

The Controversy About the H5N1 Transmissibility Experiments. resumes on lethal flu strains

The Controversy About the H5N1 Transmissibility Experiments.   resumes on lethal flu strains The Controversy About the H5N1 Transmissibility Experiments http://www.nature.com/news/work resumes on lethal flu strains 1.12266 3 M AY 2 0 1 2 VO L 4 8 5 N AT U R E 1 3 Learning Objectives Participants

More information

Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS

Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS 1 Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS What steps are involved in viral infection and replication? Why are some kinds of influenza virus more deadly than others? How do flu

More information

Grade Level: Grades 9-12 Estimated Time Allotment Part 1: One 50- minute class period Part 2: One 50- minute class period

Grade Level: Grades 9-12 Estimated Time Allotment Part 1: One 50- minute class period Part 2: One 50- minute class period The History of Vaccines Lesson Plan: Viruses and Evolution Overview and Purpose: The purpose of this lesson is to prepare students for exploring the biological basis of vaccines. Students will explore

More information

Current CEIRS Program

Current CEIRS Program History The influenza program at St. Jude has a long, distinguished history as a world-class leader in the study of the origins, evolution, and pathogenesis of influenza viruses. Based on this expertise,

More information

New Hampshire Institute for Local Public Health Practice

New Hampshire Institute for Local Public Health Practice New Hampshire Institute for Local Public Health Practice Collaborative Initiative Between The City of Manchester Health Department & The New Hampshire Department of Health and Human Services Funding provided

More information

Yale Environmental Health & Safety Update Form for Request to Use Infectious Agents Status of Protocol

Yale Environmental Health & Safety Update Form for Request to Use Infectious Agents Status of Protocol Yale Environmental Health & Safety Update Form for Request to Use Infectious Agents To update or renew the attached infectious agent registration please review the registration and complete the information

More information

Product Development for Public Health & Emerging Infections

Product Development for Public Health & Emerging Infections Product Development for Public Health & Emerging Infections Michael G Kurilla, MD-PhD Director, Office of BioDefense Research Affairs Division of Microbiology & Infectious Diseases Associate Director,

More information

Pandemic Influenza: Hype or Reality?

Pandemic Influenza: Hype or Reality? Pandemic Influenza: Hype or Reality? Leta Finch Executive Director, Higher Education Practice 2003 Arthur J. Gallagher & Co. Objectives Review key characteristics of influenza, including differences between

More information

Cloudbreak. January Cidara Therapeutics

Cloudbreak. January Cidara Therapeutics Cloudbreak January 2019 Cidara Therapeutics 2019 0 Forward-Looking Statements These slides and the accompanying oral presentation contain forward-looking statements within the meaning of the Private Securities

More information

UNDERSTANDING BIOSECURITY

UNDERSTANDING BIOSECURITY UNDERSTANDING BIOSECURITY Protecting Against the Misuse of Science in Today s World Foreword 1 Understanding Biosecurity 2 The Biosecurity Challenge 4 New Science Seeks to Conquer Old Diseases 4 Emerging

More information

Influenza Virus: Evolution of a Deadly Virus in our World

Influenza Virus: Evolution of a Deadly Virus in our World Influenza Virus: Evolution of a Deadly Virus in our World Cathy M. St. Pierre, PhD, APRN, FNP-BC, FAANP ENRM. VA HOSPITAL Bedford, Massachusetts, USA ACKNOWLEDGEMENT THIS AUTHOR WOULD LIKE TO GRATEFULLY

More information

PIP Framework Information Session 10 April 2018

PIP Framework Information Session 10 April 2018 Pandemic Influenza Preparedness Framework Sharing of influenza viruses & access to vaccines and other benefits PIP Framework Information Session 10 April 2018 PIP Framework Information Session Purpose:

More information

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON VIRUSES Biology Applications Control David R. Harper GS Garland Science Taylor & Francis Group NEW YORK AND LONDON vii Chapter 1 Virus Structure and 2.2 VIRUS MORPHOLOGY 26 Infection 1 2.3 VIRAL CLASSIFICATION

More information

Pandemic Influenza Cross Sectoral Preparedness and Planning

Pandemic Influenza Cross Sectoral Preparedness and Planning Opening statement Seminar on Pandemic Influenza Cross Sectoral Preparedness and Planning Ministry of Health and Care Services, Oslo 19. February 2009 State secretary Rigmor Aasrud Dear speakers, dear participants,

More information

Lesson 20 Study Guide: Medical Biotechnology Pandemic Flu & Emergent Disease

Lesson 20 Study Guide: Medical Biotechnology Pandemic Flu & Emergent Disease URI CMB 190 Issues in Biotechnology Lesson 20 Study Guide: Medical Biotechnology Pandemic Flu & Emergent Disease 1. The film Contagion: (A) entirely depicts a situation that could never possibly happen

More information

National Protocol on

National Protocol on National Protocol on Respiratory illnesses surveillance in Oman Rationale for proposed surveillance Method and responsibilities Surveillance for communicable diseases was launched in March 1992 Diseases

More information

Pandemic Planning Update. Anita L. Barkin, DrPH, MSN, CRNP ACHA Annual Meeting Orlando, Florida 2008

Pandemic Planning Update. Anita L. Barkin, DrPH, MSN, CRNP ACHA Annual Meeting Orlando, Florida 2008 Pandemic Planning Update Anita L. Barkin, DrPH, MSN, CRNP ACHA Annual Meeting Orlando, Florida 2008 Current Status of H5N1 383 human cases (5/29/08) 62% fatality rate Median age 18-20 previously healthy

More information

1918 Influenza; Influenza A, H1N1. Basic agent information. Section I- Infectious Agent. Section II- Dissemination

1918 Influenza; Influenza A, H1N1. Basic agent information. Section I- Infectious Agent. Section II- Dissemination 1918 Influenza; Influenza A, H1N1 Basic agent information Section I- Infectious Agent Risk Group: - RG3 Synonym or Cross reference: - Spanish Flu - 1918 Flu - El Grippe Characteristics: - SELECT AGENT

More information

Influenza. For young readers. - By Zoriana Krupa INFLUENZA 1

Influenza. For young readers. - By Zoriana Krupa INFLUENZA 1 Influenza For young readers Graphic Acknowledgement Creative Commons, no attribution required. https://pixabay.com/en/angry-bad-cute-evil-face-flu-1294144/ - By Zoriana Krupa INFLUENZA 1 Index Chapter

More information

Discovery of. 1892: Russian biologist Dmitri Ivanovsky publishes. 1931: first images of viruses obtained using

Discovery of. 1892: Russian biologist Dmitri Ivanovsky publishes. 1931: first images of viruses obtained using Discovery of (1884: invention of the Chamberland filter with pores smaller than bacteria) 1892: Russian biologist Dmitri Ivanovsky publishes a paper in which shows that extracts from diseased tobacco plants

More information

Introduction. Crowded environments where the air is re-circulated can often be heavily infected with unseen germs and viruses.

Introduction. Crowded environments where the air is re-circulated can often be heavily infected with unseen germs and viruses. Introduction The continued increase in urbanisation,, population growth and global travel means germs and viruses can spread faster and further than ever before. Air, sea, rail and road travel have never

More information

CDC s Global Disease Detection Program

CDC s Global Disease Detection Program CDC s Global Disease Program Scott F. Dowell, MD, MPH Division of Global Disease and Emergency Response Centers for Disease Control and Prevention Rationale for Global Disease It would be extremely naïve

More information

INFLUENZA FACTS AND RESOURCES

INFLUENZA FACTS AND RESOURCES U.S. HOUSE OF REPRESENTATIVES COMMITTEE ON HOMELAND SECURITY CHAIRMAN BENNIE G. THOMPSON (D-MS) INFLUENZA FACTS AND RESOURCES BACKGROUND The illness caused by the Influenza A/H1N1 virus has been called

More information

Lecture 18 Evolution and human health

Lecture 18 Evolution and human health Lecture 18 Evolution and human health Evolution and human health 1. Genetic factors 2. Infectious diseases Evolution and human health 1. Genetic factors Evolution and human health 1. Genetic factors P

More information

Adenovirus-mediated gene therapy against viral biothreat agents

Adenovirus-mediated gene therapy against viral biothreat agents r_ Transworld Research Network 37/661 (2), Fort P.O., Trivandrum-695 023, Kerala, India Recent Development in Gene Therapy, 2007: 77-94 ISBN: 81-7895-262-9 Editor: Jim Xiang Adenovirus-mediated gene therapy

More information

Supplemental Information Dose Response Parameters for Gain of Function Pathogens

Supplemental Information Dose Response Parameters for Gain of Function Pathogens Supplemental Information Dose Response Parameters for Gain of Function Pathogens Infection Dose-Response To quantify the likelihood of an individual or animal becoming infected from exposure to virus,

More information

Contribution of avian influenza data through OFFLU network

Contribution of avian influenza data through OFFLU network Dr Gounalan Pavade Chargé de Mission, OIE Headquarters Contribution of avian influenza data through OFFLU network Asia-Pacific Workshop on surveillance, prevention and control of zoonotic influenza Paro,

More information

Studying Repeated Immunization in an Animal Model. Kanta Subbarao Laboratory of Infectious Diseases, NIAID

Studying Repeated Immunization in an Animal Model. Kanta Subbarao Laboratory of Infectious Diseases, NIAID Studying Repeated Immunization in an Animal Model Kanta Subbarao Laboratory of Infectious Diseases, NIAID Animal models in Influenza Research Commonly used Mice Ferrets Guinea pigs Non human primates Less

More information

VIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks

VIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks INFLUENZA VIROLOGY OF INFLUENZA Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks PATHOGENICITY High pathogenicity avian influenza (HPAI) Causes severe disease in poultry

More information

Evolution of influenza

Evolution of influenza Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal

More information

4/28/2013. The Ever-Evolving Flu p The 1918 Flu p. 617

4/28/2013. The Ever-Evolving Flu p The 1918 Flu p. 617 The Ever-Evolving Flu p. 615 1. Influenza (Fig 18.10) rapidly evolves each year, and processes such as reassortment give rise to new genotypes. 2. Flu virus evolves rapidly to evade our immune system (Fig

More information

IMPLEMENTATION OF THE NAGOYA PROTOCOL AND PATHOGEN SHARING: PUBLIC HEALTH IMPLICATIONS

IMPLEMENTATION OF THE NAGOYA PROTOCOL AND PATHOGEN SHARING: PUBLIC HEALTH IMPLICATIONS CBD Distr. GENERAL UNEP/CBD/NP/COP-MOP/2/INF/12 6 December 2015 ENGLISH ONLY CONFERENCE OF THE PARTIES TO THE CONVENTION ON BIOLOGICAL DIVERSITY SERVING AS THE MEETING OF THE PARTIES TO THE NAGOYA PROTOCOL

More information

The risks and benefits of publishing mutant flu studies

The risks and benefits of publishing mutant flu studies NATURE NEWS: EXPLAINER The risks and benefits of publishing mutant flu studies Research describing two mutant strains of H5N1 avian influenza that spread between mammals is likely to be published in its

More information

Pandemic Preparedness 4th New Zealand Influenza Symposium. 8 February 2018 Charles Blanch, Director Emergency Management

Pandemic Preparedness 4th New Zealand Influenza Symposium. 8 February 2018 Charles Blanch, Director Emergency Management Pandemic Preparedness 4th New Zealand Influenza Symposium 8 February 2018 Charles Blanch, Director Emergency Management Cathedral Square, Christchurch NZ, Hastings Airfield Ebola Treatment Centre, Sierra

More information

Should the US develop and Stockpile Vaccines and Antiviral Medications Against. A(H5N1) Avian Flu?

Should the US develop and Stockpile Vaccines and Antiviral Medications Against. A(H5N1) Avian Flu? Spring Upshaw Biology Due: 7/7/06 Should the US develop and Stockpile Vaccines and Antiviral Medications Against A(H5N1) Avian Flu? The A(H5N1) avian flu, which has existed since 1997 is lethal in humans

More information

Center for Biologics Evaluation and Research

Center for Biologics Evaluation and Research Center for Biologics Evaluation and Research Current Activities Future Directions Washington, DC January 25, 2010 Karen Midthun, MD Acting Director, CBER CBER Our Mission To ensure the safety, purity,

More information

Patricia Fitzgerald-Bocarsly

Patricia Fitzgerald-Bocarsly FLU Patricia Fitzgerald-Bocarsly October 23, 2008 Orthomyxoviruses Orthomyxo virus (ortho = true or correct ) Negative-sense RNA virus (complementary to mrna) Five different genera Influenza A, B, C Thogotovirus

More information

School of Health Sciences PBHE 605 Quarantine 3 Credit Hours Length of Course: 8 weeks Prerequisite: None

School of Health Sciences PBHE 605 Quarantine 3 Credit Hours Length of Course: 8 weeks Prerequisite: None School of Health Sciences PBHE 605 Quarantine 3 Credit Hours Length of Course: 8 weeks Prerequisite: None Instructor Information Please refer to the Syllabus tab for your instructor s contact information

More information

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? 8 th International Conference GLOBAL HEALTH CONSORTIUM Building Alliances in Global Health Miami, May 22-25, 2018 EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? José Esparza MD, PhD - Adjunct

More information

DEFINING PANDEMIC. Dr Wan Noraini Wan Mohamed Noor Head of Surveillance Sector Disease Control Division, MOH Malaysia 3 May 2018

DEFINING PANDEMIC. Dr Wan Noraini Wan Mohamed Noor Head of Surveillance Sector Disease Control Division, MOH Malaysia 3 May 2018 DEFINING PANDEMIC Dr Wan Noraini Wan Mohamed Noor Head of Surveillance Sector Disease Control Division, MOH Malaysia 3 May 2018 drwnoraini@moh.gov.my The Outline: Natural history and spectrum of disease

More information

Influenza. Gwen Clutario, Terry Chhour, Karen Lee

Influenza. Gwen Clutario, Terry Chhour, Karen Lee Influenza Gwen Clutario, Terry Chhour, Karen Lee Overview Commonly referred to as the flu Defined as a highly contagious viral infection where it starts at the upper respiratory tract and attacks the nose,

More information

Influenza. By Allison Canestaro-Garcia. Disease Etiology:

Influenza. By Allison Canestaro-Garcia. Disease Etiology: Influenza By Allison Canestaro-Garcia Disease Etiology: The flu is an infectious disease caused by a subset of viruses of the family Orthomyxoviridae. There are 7 different viruses in this family, four

More information

The Impact of Pandemic Influenza on Public Health

The Impact of Pandemic Influenza on Public Health This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

THE WAY AHEAD. To advance fundamental knowledge in the field of. to the understanding, and the prevention of and treatment of human diseases

THE WAY AHEAD. To advance fundamental knowledge in the field of. to the understanding, and the prevention of and treatment of human diseases THE WAY AHEAD To advance fundamental knowledge in the field of molecular cell biology, and to apply such knowledge to the understanding, and the prevention of and treatment of human diseases Advances of

More information

Conflict of Interest and Disclosures. Research funding from GSK, Biofire

Conflict of Interest and Disclosures. Research funding from GSK, Biofire Pandemic Influenza Suchitra Rao, MBBS, Assistant Professor, Pediatric Infectious Diseases, Hospital Medicine and Epidemiology Global Health and Disasters Course, 2018 Conflict of Interest and Disclosures

More information

WILDLIFE DISEASE - PRESENT YET EMERGING THREAT

WILDLIFE DISEASE - PRESENT YET EMERGING THREAT WILDLIFE DISEASE - PRESENT YET EMERGING THREAT Disease whether driven by pathogens, pollutants, genetics, or dietary deficiencies can threaten vulnerable wildlife populations as significantly as do overhunting

More information

Year 9 Science STUDY GUIDE: Unit 2 Human Coordination

Year 9 Science STUDY GUIDE: Unit 2 Human Coordination Year 9 Science STUDY GUIDE: Unit 2 Human Coordination Here is a summary of the knowledge areas and learning activities you will undertake during this Focus Study. The Study commences on Monday, st February

More information

Example-exam Basics of Infectious Diseases (NEM-20806) 2015/16: [ANSWER (2 points): environment, infectious agent, and host]

Example-exam Basics of Infectious Diseases (NEM-20806) 2015/16: [ANSWER (2 points): environment, infectious agent, and host] Example-exam Basics of Infectious Diseases (NEM-20806) 2015/16: Question 1: The disease triangle is a conceptual model used to better understand the epidemiological dynamics of infectious diseases. A.

More information

Pandemic Influenza Preparedness

Pandemic Influenza Preparedness Pandemic Influenza Preparedness Of the many health threats that we are preparing for, this is the one that we know will happen. Bruce G. Gellin, MD, MPH Director, National Vaccine Program Office Department

More information

Global updates on avian influenza and tools to assess pandemic potential. Julia Fitnzer Global Influenza Programme WHO Geneva

Global updates on avian influenza and tools to assess pandemic potential. Julia Fitnzer Global Influenza Programme WHO Geneva Global updates on avian influenza and tools to assess pandemic potential Julia Fitnzer Global Influenza Programme WHO Geneva Pandemic Influenza Risk Management Advance planning and preparedness are critical

More information

DRAFT WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE GETREADYNOWGE GETREADYNOWGE GETREADYNOWGE GETREADYNOWGE.

DRAFT WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE GETREADYNOWGE GETREADYNOWGE GETREADYNOWGE GETREADYNOWGE. What Can I Do As A National Leader? This publication was produced by the AI.COMM project, managed by the Academy for Educational Development (AED), and funded by the U.S. Agency for International Development

More information

IS THE UK WELL PREPARED FOR A REPEAT OF THE 1918 INFLUENZA PANDEMIC?

IS THE UK WELL PREPARED FOR A REPEAT OF THE 1918 INFLUENZA PANDEMIC? Cambridge Judge Business School Centre for Risk Studies IS THE UK WELL PREPARED FOR A REPEAT OF THE 1918 INFLUENZA PANDEMIC? Dr Andrew Coburn Chief Scientist Cambridge Centre for Risk Studies 5 December

More information

Infection, Detection, Prevention...

Infection, Detection, Prevention... Infection, Detection, Prevention... A disease is any change that disrupts the normal function of one or more body systems. Non infectious diseases are typically caused by exposure to chemicals or are inherited.

More information

Avian Influenza (Bird Flu) Fact Sheet

Avian Influenza (Bird Flu) Fact Sheet What is an avian influenza A (H5N1) virus? Influenza A (H5N1) virus also called H5N1 virus is an influenza A virus subtype that occurs mainly in birds. It was first isolated from birds (terns) in South

More information

Planning for Pandemic Influenza in York County: Considerations for Healthcare and Medical Response

Planning for Pandemic Influenza in York County: Considerations for Healthcare and Medical Response Planning for Pandemic Influenza in York County: Considerations for Healthcare and Medical Response York County Pandemic Influenza Stakeholders Village by the Sea, Wells, Maine 8 August 2006 Steven J Trockman,

More information